Screener
Relmada Therapeutics, Inc. RLMD Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $9.78M+750% | $3.5M-9.3% | $1.38M-6.7% | $1.35M-35.1% | $1.15M-13.9% | ||
| $224.19M+765% | $89.51M+118% | $12.5M-76.2% | $19.27M-71.8% | $25.91M-68.5% | ||
| $235.34M+751% | $93.98M+105% | $14.85M-73.3% | $21.09M-70.3% | $27.66M-67.2% | ||
| —— | $3.54M+67.1% | —— | —— | —— | ||
| $235.36M+750% | $94M+105% | $14.88M-73.3% | $21.12M-70.3% | $27.68M-67.2% | ||
| $5.73M+353% | $1.57M-62.0% | $1.45M-38.0% | $1.36M-67.4% | $1.27M-75.6% | ||
| $12.89M+146% | $6.43M-37.5% | $5.19M-35.8% | $5.13M-46.2% | $5.23M-57.7% | ||
| $16.63M+217% | $7.49M-27.2% | $5.41M-33.2% | $5.17M— | $5.24M-57.6% | ||
| 150M0.0% | 150M0.0% | 150M0.0% | 150M0.0% | 150M0.0% | ||
| -$717.32M-8.9% | -$698.27M-9.0% | -$678.4M-9.0% | -$668.31M-11.3% | -$658.44M-13.0% | ||
| $218.73M+875% | $86.51M+144% | $9.47M-80.1% | $15.95M-74.1% | $22.44M-68.9% | ||
| $235.36M+750% | $94M+105% | $14.88M-73.3% | $21.12M-70.3% | $27.68M-67.2% |
FAQ
- What are Relmada Therapeutics, Inc.'s total assets?
- Relmada Therapeutics, Inc. (RLMD) holds $235.4M in total assets, up 750.3% year over year.
- How much cash does Relmada Therapeutics, Inc. have?
- Relmada Therapeutics, Inc. holds $9.8M in cash and equivalents.
- Can Relmada Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 18.26 — current assets exceed current liabilities.
- Where does Relmada Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Relmada Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.